Index -
P/E -
EPS (ttm) -2.77
Insider Own 8.24%
Shs Outstand 50.32M
Perf Week 25.74%
Market Cap 39.83M
Forward P/E -
EPS next Y -1.42
Insider Trans -1.94%
Shs Float 48.21M
Perf Month 25.84%
Income -140.94M
PEG -
EPS next Q -0.42
Inst Own 91.22%
Short Float 7.20%
Perf Quarter -12.85%
Sales 114.73M
P/S 0.35
EPS this Y 28.15%
Inst Trans -21.30%
Short Ratio 1.79
Perf Half Y -75.02%
Book/sh 0.91
P/B 0.84
EPS next Y 27.06%
ROA -46.94%
Short Interest 3.47M
Perf Year -79.21%
Cash/sh 3.38
P/C 0.23
EPS next 5Y 23.80%
ROE -141.02%
52W Range 0.44 - 6.37
Perf YTD -85.82%
Dividend Est. -
P/FCF -
EPS past 5Y -15.08%
ROI -56.79%
52W High -87.96%
Beta 2.05
Dividend TTM -
Quick Ratio 5.04
Sales past 5Y 202.67%
Gross Margin 30.97%
52W Low 76.32%
ATR (14) 0.08
Dividend Ex-Date -
Current Ratio 6.49
EPS Y/Y TTM 22.69%
Oper. Margin -112.32%
RSI (14) 66.73
Volatility 16.76% 9.24%
Employees 480
Debt/Eq 4.23
Sales Y/Y TTM -13.00%
Profit Margin -122.84%
Recom 2.25
Target Price 2.89
Option/Short Yes / Yes
LT Debt/Eq 4.19
EPS Q/Q 40.20%
Payout -
Rel Volume 0.79
Prev Close 0.78
Sales Surprise 6.81%
EPS Surprise 11.36%
Sales Q/Q -5.59%
Earnings Nov 06 AMC
Avg Volume 1.94M
Price 0.77
SMA20 27.77%
SMA50 33.02%
SMA200 -67.99%
Trades
Volume 1,529,728
Change -1.17%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$6 → $3
Jun-21-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$5 → $6
Apr-08-24 Initiated
BTIG Research
Buy
$6
Apr-05-24 Upgrade
CL King
Neutral → Buy
$6
Jan-12-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$14 → $6
Oct-13-23 Downgrade
BofA Securities
Buy → Underperform
$32 → $3
Aug-17-23 Initiated
CL King
Neutral
Nov-11-22 Initiated
RBC Capital Mkts
Outperform
$23
Jul-14-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$48 → $20
Mar-02-22 Resumed
BofA Securities
Buy
$50
Feb-17-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$50
Aug-18-21 Initiated
Cowen
Outperform
$70
Apr-19-21 Initiated
Wells Fargo
Overweight
$63
Dec-16-20 Initiated
Oppenheimer
Perform
Oct-12-20 Initiated
SVB Leerink
Mkt Perform
$60
Oct-12-20 Initiated
Stifel
Buy
$54
Oct-12-20 Initiated
Morgan Stanley
Equal-Weight
$48
Oct-12-20 Initiated
Goldman
Buy
$54
Oct-12-20 Initiated
BofA Securities
Buy
$54
Oct-12-20 Initiated
Barclays
Overweight
Show Previous Ratings
Nov-07-24 04:00PM
Nov-06-24 05:25PM
04:02PM
Nov-05-24 08:09AM
Oct-23-24 04:05PM
09:00AM
Loading…
09:00AM
Oct-18-24 04:25AM
Oct-16-24 06:56PM
Oct-14-24 01:27PM
Oct-11-24 06:45AM
Sep-27-24 08:26AM
Sep-23-24 03:57PM
Sep-20-24 09:13AM
Sep-17-24 05:45AM
Sep-13-24 05:45AM
01:23AM
Loading…
Sep-12-24 01:23AM
01:14AM
01:08AM
Sep-11-24 03:44PM
Sep-09-24 04:10PM
Sep-06-24 01:47PM
Sep-04-24 03:23PM
Sep-03-24 11:57AM
Aug-31-24 05:52PM
Aug-26-24 09:00PM
Aug-07-24 06:35PM
04:03PM
Jul-31-24 10:01AM
Jul-24-24 09:00AM
Jul-01-24 06:00AM
12:00PM
Loading…
Jun-10-24 12:00PM
Jun-03-24 04:05PM
May-13-24 06:59AM
May-10-24 03:48PM
May-09-24 03:44PM
09:42AM
(Thomson Reuters StreetEvents)
03:57AM
May-08-24 08:58PM
05:45PM
04:02PM
May-06-24 08:48AM
08:00AM
May-03-24 09:43AM
May-01-24 04:30PM
(Business Wire) +12.65%
+5.26%
Apr-19-24 08:30AM
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
Mar-05-24 03:34PM
(The Wall Street Journal)
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
(Thomson Reuters StreetEvents)
Feb-21-24 04:49PM
04:05PM
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
04:05PM
Nov-02-23 10:00AM
09:35AM
Nov-01-23 09:00AM
Oct-31-23 02:00PM
10:01AM
Oct-30-23 04:05PM
Oct-27-23 11:42AM
Oct-19-23 12:31PM
Oct-17-23 05:36PM
09:35AM
Oct-16-23 08:14AM
Oct-13-23 07:21PM
09:50AM
Oct-12-23 04:05PM
Aug-29-23 04:05PM
Aug-14-23 09:24PM
Aug-02-23 05:55PM
04:05PM
Jul-13-23 08:30AM
Jul-10-23 01:09PM
10:48AM
Jun-15-23 06:56AM
Jun-06-23 04:05PM
May-30-23 07:30AM
May-05-23 06:14AM
May-04-23 09:13AM
(Thomson Reuters StreetEvents)
May-03-23 06:35PM
04:05PM
Apr-30-23 05:50AM
Apr-25-23 08:30AM
Apr-23-23 07:03AM
Apr-12-23 09:05AM
08:30AM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trigg Leslie Chair and CEO Aug 15 '24 Sale 0.84 5,308 4,459 910,496 Aug 15 08:02 PM Nash Marc SVP Operations and R&D Aug 15 '24 Sale 0.84 1,293 1,086 239,397 Aug 15 08:01 PM Brottem John L. General Counsel Aug 15 '24 Sale 0.84 3,011 2,529 230,295 Aug 15 07:59 PM Ahmed Nabeel Chief Financial Officer Aug 15 '24 Sale 0.84 3,971 3,336 314,988 Aug 15 07:57 PM Trigg Leslie Officer Aug 15 '24 Proposed Sale 0.84 5,308 4,459 Aug 15 06:49 PM Nash Marc Officer Aug 15 '24 Proposed Sale 0.84 1,293 1,086 Aug 15 06:49 PM Brottem John L. Officer Aug 15 '24 Proposed Sale 0.84 3,011 2,529 Aug 15 06:47 PM Ahmed Nabeel Officer Aug 15 '24 Proposed Sale 0.84 3,971 3,336 Aug 15 06:46 PM Nash Marc SVP Operations and R&D Jul 24 '24 Sale 4.02 723 2,906 240,690 Jul 24 07:08 PM Brottem John L. General Counsel Jun 12 '24 Sale 4.78 10,569 50,520 233,306 Jun 14 04:17 PM GROSSMAN D KEITH Director Jun 03 '24 Option Exercise 1.11 69,303 76,926 85,922 Jun 03 06:57 PM GROSSMAN D KEITH Director Jun 03 '24 Sale 3.78 38,117 144,234 47,805 Jun 03 06:57 PM Ahmed Nabeel Chief Financial Officer May 16 '24 Sale 3.53 3,918 13,831 318,959 May 17 05:40 PM Nash Marc SVP Operations and R&D May 16 '24 Sale 3.53 1,097 3,872 241,413 May 17 05:38 PM Brottem John L. General Counsel May 16 '24 Sale 3.53 2,972 10,491 243,875 May 17 05:36 PM Trigg Leslie Chair and CEO May 16 '24 Sale 3.53 5,237 18,487 915,804 May 17 05:25 PM Racine Jean-Olivier Chief Technology Officer May 10 '24 Sale 3.27 8,306 27,161 265,325 May 10 06:19 PM Nash Marc SVP Operations and R&D Mar 15 '24 Sale 2.13 2,391 5,093 242,510 Mar 15 06:40 PM Ahmed Nabeel Chief Financial Officer Mar 01 '24 Sale 3.15 1,584 4,990 322,877 Mar 04 04:34 PM Williamson Steven S. Chief Commercial Officer Feb 15 '24 Sale 3.57 2,500 8,925 320,347 Feb 16 05:31 PM Trigg Leslie Chair and CEO Feb 15 '24 Sale 3.57 5,320 18,992 833,091 Feb 16 05:29 PM Racine Jean-Olivier Chief Technology Officer Feb 15 '24 Sale 3.57 1,866 6,662 271,830 Feb 16 05:28 PM Nash Marc SVP Operations and R&D Feb 15 '24 Sale 3.57 617 2,203 243,100 Feb 16 05:27 PM Brottem John L. General Counsel Feb 15 '24 Sale 3.57 3,341 11,927 245,046 Feb 16 05:26 PM Ahmed Nabeel Chief Financial Officer Feb 15 '24 Sale 3.57 4,403 15,719 312,594 Feb 16 05:24 PM Williamson Steven S. Chief Commercial Officer Jan 16 '24 Sale 4.29 996 4,273 322,847 Jan 17 08:04 PM Trigg Leslie Chair and CEO Jan 16 '24 Sale 4.29 8,126 34,861 838,411 Jan 17 08:03 PM Racine Jean-Olivier Chief Technology Officer Jan 16 '24 Sale 4.29 723 3,102 273,696 Jan 17 08:03 PM Porter Stacey L. Chief People Officer Jan 16 '24 Sale 4.29 768 3,295 61,448 Jan 17 08:02 PM Nash Marc SVP Operations and R&D Jan 16 '24 Sale 429.00 678 290,862 243,717 Jan 17 08:01 PM Brottem John L. General Counsel Jan 16 '24 Sale 4.29 1,480 6,349 248,387 Jan 17 08:00 PM Ahmed Nabeel Chief Financial Officer Jan 16 '24 Sale 4.29 1,726 7,405 316,997 Jan 17 07:59 PM Williamson Steven S. Chief Commercial Officer Jan 08 '24 Sale 5.49 7,055 38,732 105,939 Jan 08 08:35 PM Trigg Leslie Chair and CEO Jan 08 '24 Sale 5.49 14,188 77,892 389,099 Jan 08 08:34 PM Racine Jean-Olivier Chief Technology Officer Jan 08 '24 Sale 5.49 3,905 21,438 73,781 Jan 08 08:33 PM Porter Stacey L. Chief People Officer Jan 08 '24 Sale 5.49 4,766 26,165 58,630 Jan 08 08:31 PM Brottem John L. General Counsel Jan 08 '24 Sale 5.49 7,344 40,319 48,807 Jan 08 08:30 PM Ahmed Nabeel Chief Financial Officer Jan 08 '24 Sale 5.49 10,709 58,792 76,819 Jan 08 08:29 PM Williamson Steven S. Chief Commercial Officer Nov 16 '23 Sale 4.76 3,584 17,060 112,994 Nov 17 04:22 PM Trigg Leslie Chair and CEO Nov 16 '23 Sale 4.76 3,175 15,113 403,287 Nov 17 04:19 PM Racine Jean-Olivier Chief Technology Officer Nov 16 '23 Sale 4.76 790 3,760 77,686 Nov 17 04:18 PM Porter Stacey L. Chief People Officer Nov 16 '23 Sale 4.76 671 3,194 63,396 Nov 17 04:17 PM Nash Marc SVP Operations and R&D Nov 16 '23 Sale 4.76 562 2,675 44,757 Nov 17 04:15 PM Brottem John L. General Counsel Nov 16 '23 Sale 4.76 1,431 6,812 56,151 Nov 17 04:15 PM Ahmed Nabeel Chief Financial Officer Nov 16 '23 Sale 4.76 1,643 7,821 87,528 Nov 17 04:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite